摘要
胰高血糖素样肽1(GLP-1)是目前用于治疗2型糖尿病的新型药物,因其以葡萄糖依赖方式刺激胰岛素释放而得到广泛应用。脂肪因子是由脂肪细胞分泌的活性因子,可以参与体内多种代谢功能的调节,并在许多疾病的发生、发展中发挥关键作用。因此,深入研究GLP-1对脂肪因子的调节作用,将为更好地应用GLP-1治疗代谢性疾病提供依据。
Glucagon-like peptide-1( GLP-1) is widely used in the treatment of type 2 diabetes mellitus because of stimulating glucose-dependent insulin secretion in pancreatic β cells. Adipocytokines are secreted by adipocytes,involved in multiple metabolic functions in vivo and play a key role in the development of many diseases. The research on the regulation of GLP-1 to adipokines,will provide a new way to the treatment of metabolism diseases.
出处
《医学综述》
2015年第16期2884-2887,共4页
Medical Recapitulate
基金
国家自然科学基金(81370956)
上海交通大学无锡研究院交大专项资金(2011JDZX021)